If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Directorate Change

4 Dec 2019 13:30

RNS Number : 6859V
Reckitt Benckiser Group PLC
04 December 2019
 

 

RB ANNOUNCES CHANGES TO EXECUTIVE TEAM

December 4, 2019 - Reckitt Benckiser Group plc, ("RB") today announces a series of management changes which will focus on delivering the next phase of transformation and continue to evolve the strong culture of the business.

Harold van den Broek, currently CFO of Hygiene Home, is appointed Chief Operating Officer of the Hygiene Home business unit and join the company's Executive Committee, reporting to Group CEO Laxman Narasimhan. Rob de Groot, President, Hygiene Home is stepping down from his role today and will leave the company in February 2020 after a handover period with Harold.

Group CEO Laxman Narasimhan said about the changes: "I would like to thank Rob for his 32 years of distinguished service. As President of Hygiene Home he has led the significant improvement in performance of the brands and created a strong purpose-led organisation, passionate about sustainability. I look forward to working with Harold, who has been a strategic partner to Rob throughout the establishment of Hygiene Home business unit, and is known for inspiring teams to deliver growth, with operational rigour."

Kris Licht, joined RB in November from Pepsico, taking up the newly created role of Chief Transformation Officer and will also be a member of the Executive Committee. Kris was most recently Division President for Pepsi Beverages North America. Prior to this role, Kris led the North East Division of PepsiCo Beverages North America and also held the role of Commercial Transformation for PepsiCo Beverages North America. Kris will help in creating and implementing a roadmap for our strategy and portfolio and supporting the transformation of our execution capabilities.

These appointments follow the recent announcement of Jeff Carr's appointment as Group Chief Financial Officer, replacing Adrian Hennah who has held the post since 2013. Jeff joins RB from his current role as Chief Financial Officer, Management Board and Executive Committee member at Ahold Delhaize, where he has been since 2011. Jeff began his career at Unilever as a graduate trainee and has held senior roles at Grand Metropolitan plc, Associated British Foods plc, easyJet plc and First Group plc and in senior finance roles in RB between 1994-2004. Jeff also serves as non-executive director of Kingfisher plc.

Laxman added: "I am extremely pleased to welcome Kris, Jeff and Harold to the leadership team of RB. They will help write the next chapter RB's history. I look forward to working with this exceptional group of leaders."

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

 

About RB

 

RB is the global leading consumer health, hygiene and home company. Driven by a purpose to build healthier lives and happier homes, RB has operations in over 60 countries. From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, our global brands help people live healthier, happier lives. RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. RB's unique culture is at the heart of its success. Its drive to achieve, passion to outperform and commitment to quality and scientific excellence are manifested in the work of over 40,000 RB employees worldwide.

 

For further information, please contact:

 

RB +44 (0)1753 217800

 

Richard Joyce

SVP, Investor Relations

 

Patty O'Hayer

Director, External Relations and Government Affairs

 

Finsbury +44 (0)20 7251 3801

Faeth Birch

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGGRCPUPBGPC
Date   Source Headline
22nd Jan 20154:55 pmRNSShare repurchase
21st Jan 20155:19 pmRNSShare repurchase
20th Jan 20154:51 pmRNSShare repurchase
19th Jan 20155:06 pmRNSShare repurchase
16th Jan 20154:46 pmRNSShare repurchase
15th Jan 20155:18 pmRNSShare repurchase
14th Jan 20155:00 pmRNSShare repurchase
13th Jan 20154:56 pmRNSShare repurchase
12th Jan 20155:00 pmRNSShare repurchase
9th Jan 20154:53 pmRNSShare repurchase
8th Jan 20154:53 pmRNSShare repurchase
7th Jan 20154:51 pmRNSShare repurchase
6th Jan 20155:46 pmRNSShare repurchase
6th Jan 20154:00 pmRNSDirector/PDMR Shareholding
5th Jan 20155:13 pmRNSShare repurchase
2nd Jan 20155:48 pmRNSShare repurchase
31st Dec 201411:15 amRNSTotal Voting Rights
23rd Dec 20149:45 amRNSDirector Declaration
23rd Dec 20148:00 amRNSRB completes demerger of Indivior
18th Dec 201410:39 amRNSFrench Competition Fine
12th Dec 20146:21 pmRNSDirector/PDMR Shareholding
12th Dec 20145:00 pmRNSShare Repurchase Programme
10th Dec 20141:14 pmRNSChairman's proxy votes for GM on 11 December 2014
4th Dec 20145:45 pmRNSShare repurchase
4th Dec 201412:40 pmRNSDirector/PDMR Shareholding
3rd Dec 20145:26 pmRNSShare repurchase
2nd Dec 20145:18 pmRNSShare repurchase
2nd Dec 20145:01 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:58 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:53 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:50 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:47 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:40 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:37 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:34 pmRNSDirector/PDMR Shareholding
1st Dec 20145:13 pmRNSShare repurchase
1st Dec 20142:06 pmRNSExecutive Committee Changes
28th Nov 20145:20 pmRNSTotal Voting Rights
28th Nov 20145:14 pmRNSShare repurchase
27th Nov 20144:58 pmRNSShare repurchase
26th Nov 20145:19 pmRNSShare repurchase
25th Nov 20145:13 pmRNSShare repurchase
24th Nov 20145:20 pmRNSShare repurchase
21st Nov 20145:11 pmRNSShare repurchase
20th Nov 20144:51 pmRNSShare repurchase
19th Nov 20144:56 pmRNSShare repurchase
18th Nov 20145:05 pmRNSShare repurchase
17th Nov 20144:55 pmRNSShare repurchase
17th Nov 20144:36 pmRNSCircular re Demerger and Notice of General Meeting
17th Nov 20147:00 amRNSProposed Demerger of the RB Pharma business

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.